the Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Spastic Stroke Patient. The Patients Were Diagnosed With the Lateral Scapular Slide Test, Fugl-Meyer Upper Extremity (FMUE) Scale Scores & Scapular Balance Angle Test (SBA).

The Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Stroke Patients With Spasticity

to investigate the effect of Scapular dyskinesia on the scapular balance angle & upper extremity Sensorimotor Function in spastic stroke patient.

Study Overview

• Status: Completed
• Conditions: Post Stroke Scapular Dyskinesia
• Intervention / Treatment: Other: Assessment of scapular balance angle and upper extremity sensorimotor function

Detailed Description

Background: Post stroke Scapular dyskinesia leads to scapulohumeral pain & dysfunction were associated with decreased motor function, somatosensory function, limited range of motion, and spasticity.

Objective: to investigate the effect of Scapular dyskinesia on the scapular balance angle & upper extremity Sensorimotor Function in spastic stroke patient.

Methods: sixty patients from both sexes were participated in this study. All the patients were diagnosed as spastic stroke patients. The patients were divided into two equal groups; group A (30 patients): with high scapular dyskinesia scores, group B (30 patients): with low or no scapular dyskinesia scores. The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores & scapular balance angle test (SBA).

• Study Type: Observational
• Enrollment (Actual): 60

Contacts and Locations

Study Locations

• Egypt
  • El-Sheikh Zayed City Giza 1133 Egypt
    • Giza, El-Sheikh Zayed City Giza 1133 Egypt, Egypt
      • October 6 University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 35 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Sixty stroke patients were randomly selected from Kasr El-Aini Neurological Department, outpatient clinic of Faculty of Physical Therapy, Cairo University, October 6 university hospital.

Description

Inclusion Criteria:

• patient diagnosed as stroke patient
• stroke onset at least 5 months prior to study enrollment and
• decreased sensorimotor function in the affected arm, but ability to use the arm to some extent in daily activities with functional to subfunctional manual muscle test
• age ranged from 35:50
• both sexes

Exclusion Criteria:

• difficulty to communicate or to understand test instructions
• other conditions that caused pain (for example fibromyalgia and arthritis)
• severe depression or other psychiatric symptoms
• patient with other upper limb musculoskeletal problems

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Control
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
study group (high scapular dyskinesia ); group A (30 patients): with high scapular dyskinesia scores	Other: Assessment of scapular balance angle and upper extremity sensorimotor function; The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores & scapular balance angle test (SBA).
control group (low or no scapular dyskinesia ); group B (30 patients): with low or no scapular dyskinesia scores. (30 patients): with low or no scapular dyskinesia scores.	Other: Assessment of scapular balance angle and upper extremity sensorimotor function; The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores & scapular balance angle test (SBA).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
the Lateral scapular slide test	for the measurement of scapular dyskinesia, the Lateral scapular slide test using Palpation meter (PALM) device, marked inferior angles of scapula and the other arm was moved to reach the marked corresponding spinous process Both sides' readings were recorded and the differences between them were calculated Bilateral difference of 1.5 cm considered the threshold for deciding whether scapular asymmetry is abnormal A distance 1.5 cm greater than the contralateral side in any position suggests scapulothoracic weakness with secondary scapulothoracic protraction	1 day
Fugl-Meyer Assessment (FMA) scale	Fugl-Meyer upper extremity (FMUE) Scale scores is an index to assess the sensorimotor impairment in individuals who had stroke. The motor section score ranges from 0 to 66, and the score related to exteroceptive and proprioceptive sensitivity ranges from 0 to 12. The lowest and highest scores correspond to worse and better function, respectively FMUE Scale scores < 31 corresponded with 'no to poor' upper extremity capacity, while 32 to 47 represented 'limited capacity', 48 to 52 represented 'notable capacity' and 53 to 66 represented 'full' upper extremity capacity	1 day
scapular balance angle (SBA):	for Measurement of scapular balance angle The inferior angle of the scapula was marked bilaterally and a line was drawn connecting these marks. Another vertical line between C7 and T10 spinous processes was drawn. The angles formed by the line joining both inferior angles of the scapula with the vertical line running through the spine were measured (The difference between these two angles corresponded to the scapular balance angle The values for the SBA in healthy population were 2.505±2.340° while the abnormality criteria were with an angle greater than 7.185°	1 day

Collaborators and Investigators

• Sponsor: Lama Saad El-Din Mahmoud

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2019
• Primary Completion (Actual): June 5, 2019
• Study Completion (Actual): June 5, 2019

Study Registration Dates

• First Submitted: June 28, 2019
• First Submitted That Met QC Criteria: July 1, 2019
• First Posted (Actual): July 2, 2019

Study Record Updates

• Last Update Posted (Actual): August 27, 2020
• Last Update Submitted That Met QC Criteria: August 25, 2020
• Last Verified: August 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Movement Disorders; Stroke; Dyskinesias
• Other Study ID Numbers: 12341234

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided
• IPD Plan Description: publication research study

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No